ID   EF2K_HUMAN              Reviewed;         725 AA.
AC   O00418; Q8N588;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   02-NOV-2010, entry version 100.
DE   RecName: Full=Eukaryotic elongation factor 2 kinase;
DE            Short=eEF-2 kinase;
DE            Short=eEF-2K;
DE            EC=2.7.11.20;
DE   AltName: Full=Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;
GN   Name=EEF2K;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-361.
RC   TISSUE=Glial tumor;
RX   MEDLINE=97289688; PubMed=9144159; DOI=10.1073/pnas.94.10.4884;
RA   Ryazanov A.G., Ward M.D., Mendola C.E., Pavur K.S., Dorovkov M.V.,
RA   Wiedmann M., Erdjument-Bromage H., Tempst P., Parmer T.G.,
RA   Prostko C.R., Germino F.J., Hait W.N.;
RT   "Identification of a new class of protein kinases represented by
RT   eukaryotic elongation factor-2 kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4884-4889(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-23 AND
RP   ARG-361.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-27; SER-31;
RP   TYR-69; SER-70; SER-470 AND SER-474, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-445, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; THR-348; SER-470;
RP   SER-474 AND SER-477, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-27; SER-31;
RP   SER-470 AND SER-474, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-470, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-23; ALA-75; MET-291; TRP-433 AND
RP   HIS-609.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates eukaryotic elongation factor-2. Binds
CC       calmodulin (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + [elongation factor 2] = ADP +
CC       [elongation factor 2] phosphate.
CC   -!- ENZYME REGULATION: Undergoes calcium/calmodulin-dependent
CC       intramolecular autophosphorylation, and this results in it
CC       becoming partially calcium/calmodulin-independent (By similarity).
CC   -!- SUBUNIT: Monomer or homodimer (Potential).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Alpha-type
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 alpha-type protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U93850; AAB58270.1; -; mRNA.
DR   EMBL; AC009034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032665; AAH32665.1; -; mRNA.
DR   IPI; IPI00011689; -.
DR   RefSeq; NP_037434.1; -.
DR   UniGene; Hs.498892; -.
DR   ProteinModelPortal; O00418; -.
DR   MINT; MINT-207181; -.
DR   STRING; O00418; -.
DR   PhosphoSite; O00418; -.
DR   PRIDE; O00418; -.
DR   Ensembl; ENST00000263026; ENSP00000263026; ENSG00000103319.
DR   GeneID; 29904; -.
DR   KEGG; hsa:29904; -.
DR   UCSC; uc002dki.1; human.
DR   CTD; 29904; -.
DR   GeneCards; GC16P022217; -.
DR   H-InvDB; HIX0202251; -.
DR   HGNC; HGNC:24615; EEF2K.
DR   HPA; CAB007818; -.
DR   MIM; 606968; gene.
DR   PharmGKB; PA134992891; -.
DR   eggNOG; prNOG07338; -.
DR   HOGENOM; HBG717344; -.
DR   HOVERGEN; HBG002318; -.
DR   InParanoid; O00418; -.
DR   OMA; HKPPKQV; -.
DR   OrthoDB; EOG94QWK9; -.
DR   BRENDA; 2.7.11.20; 247.
DR   Pathway_Interaction_DB; p38gammadeltapathway; Signaling mediated by p38-gamma and p38-delta.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   NextBio; 52478; -.
DR   ArrayExpress; O00418; -.
DR   Bgee; O00418; -.
DR   CleanEx; HS_EEF2K; -.
DR   Genevestigator; O00418; -.
DR   GermOnline; ENSG00000103319; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004686; F:elongation factor-2 kinase activity; IEA:EC.
DR   GO; GO:0008135; F:translation factor activity, nucleic acid b...; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0006414; P:translational elongation; TAS:ProtInc.
DR   InterPro; IPR017400; Elongation_factor_2_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR004166; MHCK_EF2_kinase.
DR   InterPro; IPR006597; Sel1-like.
DR   InterPro; IPR011990; TPR-like_helical.
DR   Gene3D; G3DSA:1.25.40.10; TPR-like_helical; 1.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   Pfam; PF08238; Sel1; 4.
DR   PIRSF; PIRSF038139; Elongation_factor_2_kinase; 1.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Calcium; Calmodulin-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    725       Eukaryotic elongation factor 2 kinase.
FT                                /FTId=PRO_0000086936.
FT   DOMAIN      116    326       Alpha-type protein kinase.
FT   NP_BIND     296    302       ATP (By similarity).
FT   REGION      594    610       Calmodulin-binding (Potential).
FT   REGION      610    627       Pseudosubstrate/autoinhibitory domain
FT                                (Potential).
FT   MOD_RES      18     18       Phosphoserine.
FT   MOD_RES      27     27       Phosphoserine.
FT   MOD_RES      31     31       Phosphoserine.
FT   MOD_RES      69     69       Phosphotyrosine.
FT   MOD_RES      70     70       Phosphoserine.
FT   MOD_RES      71     71       Phosphoserine (By similarity).
FT   MOD_RES     135    135       Phosphoserine.
FT   MOD_RES     348    348       Phosphothreonine.
FT   MOD_RES     445    445       Phosphoserine.
FT   MOD_RES     470    470       Phosphoserine.
FT   MOD_RES     474    474       Phosphoserine.
FT   MOD_RES     477    477       Phosphoserine.
FT   VARIANT      23     23       H -> R (in dbSNP:rs9935059).
FT                                /FTId=VAR_033915.
FT   VARIANT      75     75       P -> A (in dbSNP:rs17841292).
FT                                /FTId=VAR_033916.
FT   VARIANT     291    291       T -> M (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041534.
FT   VARIANT     361    361       Q -> R (in dbSNP:rs4783453).
FT                                /FTId=VAR_058405.
FT   VARIANT     433    433       R -> W (in dbSNP:rs56137739).
FT                                /FTId=VAR_041535.
FT   VARIANT     609    609       D -> H.
FT                                /FTId=VAR_041536.
SQ   SEQUENCE   725 AA;  82144 MW;  9D2900E50EFF12DA CRC64;
     MADEDLIFRL EGVDGGQSPR AGHDGDSDGD SDDEEGYFIC PITDDPSSNQ NVNSKVNKYY
     SNLTKSERYS SSGSPANSFH FKEAWKHAIQ KAKHMPDPWA EFHLEDIATE RATRHRYNAV
     TGEWLDDEVL IKMASQPFGR GAMRECFRTK KLSNFLHAQQ WKGASNYVAK RYIEPVDRDV
     YFEDVRLQME AKLWGEEYNR HKPPKQVDIM QMCIIELKDR PGKPLFHLEH YIEGKYIKYN
     SNSGFVRDDN IRLTPQAFSH FTFERSGHQL IVVDIQGVGD LYTDPQIHTE TGTDFGDGNL
     GVRGMALFFY SHACNRICES MGLAPFDLSP RERDAVNQNT KLLQSAKTIL RGTEEKCGSP
     QVRTLSGSRP PLLRPLSENS GDENMSDVTF DSLPSSPSSA TPHSQKLDHL HWPVFSDLDN
     MASRDHDHLD NHRESENSGD SGYPSEKRGE LDDPEPREHG HSYSNRKYES DEDSLGSSGR
     VCVEKWNLLN SSRLHLPRAS AVALEVQRLN ALDLEKKIGK SILGKVHLAM VRYHEGGRFC
     EKGEEWDQES AVFHLEHAAN LGELEAIVGL GLMYSQLPHH ILADVSLKET EENKTKGFDY
     LLKAAEAGDR QSMILVARAF DSGQNLSPDR CQDWLEALHW YNTALEMTDC DEGGEYDGMQ
     DEPRYMMLAR EAEMLFTGGY GLEKDPQRSG DLYTQAAEAA MEAMKGRLAN QYYQKAEEAW
     AQMEE
//
